Atomo Diagnostics (ASX:AT1) OCF Margin %: -45.23% (As of Dec. 2025)


What is Atomo Diagnostics OCF Margin %?

Atomo Diagnostics ASX:AT1 OCF Margin % is -45.23% as of Dec. 2025. The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Atomo Diagnostics ranks worse than 81.23% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Atomo Diagnostics's Cash Flow from Operations for the six months ended in Dec. 2025 was A$-0.96 Mil. Atomo Diagnostics's Revenue for the six months ended in Dec. 2025 was A$2.13 Mil. Therefore, Atomo Diagnostics's OCF Margin % for the quarter that ended in Dec. 2025 was -45.23%.

As of today, Atomo Diagnostics's current OCF Yield % is -12.18%.

The historical rank and industry rank for Atomo Diagnostics's OCF Margin % or its related term are showing as below:

ASX:AT1' s OCF Margin % Range Over the Past 10 Years
Min: -317.71   Med: -88.79   Max: -22.75
Current: -62.98

During the past 6 years, the highest OCF Margin % of Atomo Diagnostics was -22.75%. The lowest was -317.71%. And the median was -88.79%.

ASX:AT1's OCF Margin % is ranked worse than
81.23% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs ASX:AT1: -62.98

Atomo Diagnostics OCF Margin % Related Terms

Atomo Diagnostics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Atomo Diagnostics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atomo Diagnostics OCF Margin % Chart

Atomo Diagnostics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
OCF Margin %
Get a 7-Day Free Trial -62.91 -22.75 -229.87 -114.66 -60.31

Atomo Diagnostics Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -97.87 -129.63 -38.42 -90.86 -45.23

ASX:AT1 vs ABT, SYK, MDT: OCF Margin % Comparison

For the Medical Devices subindustry, Atomo Diagnostics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atomo Diagnostics OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Atomo Diagnostics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Atomo Diagnostics's OCF Margin % falls into.


Atomo Diagnostics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Atomo Diagnostics's OCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-1.959/3.248
=-60.31 %

Atomo Diagnostics's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.963/2.129
=-45.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -45.23% mean?
Atomo Diagnostics (ASX:AT1) has a OCF Margin % of -45.23% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Atomo Diagnostics and its competitors. According to the industry distribution chart, Atomo Diagnostics ranks #662 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 81.2%.
Is Atomo Diagnostics' OCF Margin % too high?
Atomo Diagnostics' current OCF Margin % is -45.23%. Based on the distribution chart, Atomo Diagnostics ranks #662 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Atomo Diagnostics' OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Atomo Diagnostics ranks #662 out of 815 companies for OCF Margin %. This places Atomo Diagnostics in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Atomo Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Atomo Diagnostics's current OCF Margin % is -45.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atomo Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Atomo Diagnostics (ASX:AT1) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.02 — trading 15% below its estimated fair value. The current OCF Margin % is -45.23%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Atomo Diagnostics (ASX:AT1), the current OCF Margin % is -45.23% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atomo Diagnostics Business Description

Address 3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.